Logo image of HCWC

HEALTHY CHOICE WELLNESS CORP (HCWC) Stock Fundamental Analysis

NYSEARCA:HCWC - NYSE Arca - US42227T1051 - Common Stock - Currency: USD

0.4151  -0.01 (-2.65%)

Fundamental Rating

2

HCWC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 41 industry peers in the Consumer Staples Distribution & Retail industry. HCWC has a bad profitability rating. Also its financial health evaluation is rather negative. HCWC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HCWC has reported negative net income.
HCWC had a negative operating cash flow in the past year.
HCWC Yearly Net Income VS EBIT VS OCF VS FCFHCWC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -13.21%, HCWC is doing worse than 82.93% of the companies in the same industry.
Looking at the Return On Equity, with a value of -189.35%, HCWC is doing worse than 95.12% of the companies in the same industry.
Industry RankSector Rank
ROA -13.21%
ROE -189.35%
ROIC N/A
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCWC Yearly ROA, ROE, ROICHCWC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Gross Margin of HCWC (39.02%) is better than 87.80% of its industry peers.
In the last couple of years the Gross Margin of HCWC has grown nicely.
HCWC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
HCWC Yearly Profit, Operating, Gross MarginsHCWC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

HCWC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HCWC remains at a similar level compared to 1 year ago.
Compared to 1 year ago, HCWC has a worse debt to assets ratio.
HCWC Yearly Shares OutstandingHCWC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
HCWC Yearly Total Debt VS Total AssetsHCWC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 1.83 indicates that HCWC is not a great score, but indicates only limited risk for bankruptcy at the moment.
HCWC's Altman-Z score of 1.83 is on the low side compared to the rest of the industry. HCWC is outperformed by 75.61% of its industry peers.
A Debt/Equity ratio of 3.87 is on the high side and indicates that HCWC has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 3.87, HCWC is doing worse than 92.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.87
Debt/FCF N/A
Altman-Z 1.83
ROIC/WACCN/A
WACC11.91%
HCWC Yearly LT Debt VS Equity VS FCFHCWC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

HCWC has a Current Ratio of 0.81. This is a bad value and indicates that HCWC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.81, HCWC is not doing good in the industry: 80.49% of the companies in the same industry are doing better.
HCWC has a Quick Ratio of 0.81. This is a bad value and indicates that HCWC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.27, HCWC is not doing good in the industry: 73.17% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.27
HCWC Yearly Current Assets VS Current LiabilitesHCWC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.68% over the past year.
Looking at the last year, HCWC shows a very strong growth in Revenue. The Revenue has grown by 24.57%.
HCWC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 83.46% yearly.
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, HCWC will show a very strong growth in Earnings Per Share. The EPS will grow by 40.41% on average per year.
HCWC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.98% yearly.
EPS Next Y40%
EPS Next 2Y40.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.88%
Revenue Next 2Y13.98%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HCWC Yearly Revenue VS EstimatesHCWC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
HCWC Yearly EPS VS EstimatesHCWC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCWC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HCWC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCWC Price Earnings VS Forward Price EarningsHCWC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCWC Per share dataHCWC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as HCWC's earnings are expected to grow with 40.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.41%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HCWC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALTHY CHOICE WELLNESS CORP

NYSEARCA:HCWC (6/12/2025, 12:46:46 PM)

0.4151

-0.01 (-2.65%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-09 2025-05-09/amc
Earnings (Next)N/A N/A
Inst Owners2.49%
Inst Owner Change-40.12%
Ins Owners18.11%
Ins Owner Change0%
Market Cap5.04M
Analysts82.86
Price Target2.04 (391.45%)
Short Float %0.93%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 2.12
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS5.71
BVpS0.2
TBVpS-0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.21%
ROE -189.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.02%
FCFM N/A
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
F-Score5
Asset Turnover2.03
Health
Industry RankSector Rank
Debt/Equity 3.87
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.97%
Cap/Sales 0.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.27
Altman-Z 1.83
F-Score5
WACC11.91%
ROIC/WACCN/A
Cap/Depr(3y)22.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y40%
EPS Next 2Y40.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year13.88%
Revenue Next 2Y13.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.36%
OCF growth 3YN/A
OCF growth 5YN/A